Cytogel Pharma
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Thorndal Cir, Darien, Connecticut, 068...Phone Number
(203) 662-6617Website
www.cytogelpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cytogel Pharma
Cytogel Pharma is a clinical stage biopharmaceutical company focused on developing first-in-class drug candidates from the novel endomorphin family of peptides to provide effective pain relief. Their lead product, CYT-1010, targets key pain pathways with a unique mechanism of action, aiming to alleviate moderate to severe pain while minimizing addiction potential and respiratory depression. The company is dedicated to transforming pain management for patients and healthcare practitioners by offering a safer alternative to traditional pain treatments. With a commitment to scientific evidence and clinical proof of concept, Cytogel Pharma seeks to make significant contributions to pain relief therapies.Explore more
Cytogel Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytogel Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cytogel Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cytogel Pharma is spiking on competitors!
Click to see if Cytogel Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Cytogel Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cytogel Pharma
Website visits: Recent activity has been detected on your website
Check if Cytogel Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cytogel Pharma launches new products
Cytogel Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Cytogel Pharma as Masked Content
Find more new buyers
Compare Similar Companies to Cytogel Pharma
Compare insights from companies similar to Cytogel Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cytogel Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cytogel Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cytogel Pharma.
Cytogel Pharma financials insights
Gather financial insights about Cytogel Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Private Equity
$2.2M
2013
Debt
$750K
2015
Private Equity
$2.7M
Cytogel Pharma Tech Stack
A closer look at the technologies used by Cytogel Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cytogel Pharma
Sign Up For FreeTo access detailed company insights
Cytogel Pharma is a clinical stage biopharmaceutical company focused on developing first-in-class drug candidates from the novel endomorphin family of peptides to provide effective pain relief. Their lead product, CYT-1010, targets key pain pathways with a unique mechanism of action, aiming to alleviate moderate to severe pain while minimizing addi... Read More
